244 related articles for article (PubMed ID: 28235250)
1. Brief Report: The Euro-Lupus Low-Dose Intravenous Cyclophosphamide Regimen Does Not Impact the Ovarian Reserve, as Measured by Serum Levels of Anti-Müllerian Hormone.
Tamirou F; Husson SN; Gruson D; Debiève F; Lauwerys BR; Houssiau FA
Arthritis Rheumatol; 2017 Jun; 69(6):1267-1271. PubMed ID: 28235250
[TBL] [Abstract][Full Text] [Related]
2. Assessment of ovarian reserve by serum anti-Müllerian hormone in patients with systemic lupus erythematosus: a meta-analysis.
Luo W; Mao P; Zhang L; Chen X; Yang Z
Ann Palliat Med; 2020 Mar; 9(2):207-215. PubMed ID: 32156138
[TBL] [Abstract][Full Text] [Related]
3. Anti-müllerian hormone and ovarian reserve in systemic lupus erythematosus.
Mok CC; Chan PT; To CH
Arthritis Rheum; 2013 Jan; 65(1):206-10. PubMed ID: 23044647
[TBL] [Abstract][Full Text] [Related]
4. Anti-Müllerian hormone serum levels in systemic lupus erythematosus patients: Influence of the disease severity and therapy on the ovarian reserve.
Di Mario C; Petricca L; Gigante MR; Barini A; Barini A; Varriano V; Paglionico A; Cattani P; Ferraccioli G; Tolusso B; Gremese E
Endocrine; 2019 Feb; 63(2):369-375. PubMed ID: 30324323
[TBL] [Abstract][Full Text] [Related]
5. [Assessment of ovarian reserve with anti-Müllerian hormone in female patients with systemic lupus erythematosus].
Chen D; Yuan S; Zhan Z; Zhan Y; Yang X; Liang L
Zhonghua Yi Xue Za Zhi; 2014 Apr; 94(13):977-80. PubMed ID: 24851682
[TBL] [Abstract][Full Text] [Related]
6. Anti-Müllerian hormone in reproductive age women with systemic lupus erythematosus.
Velarde-Ochoa Mdel C; Esquivel-Valerio JA; Vega-Morales D; Skinner-Taylor CM; Galarza-Delgado DÁ; Garza-Elizondo MA
Reumatol Clin; 2015; 11(2):78-82. PubMed ID: 24815955
[TBL] [Abstract][Full Text] [Related]
7. Adjunctive GnRH-a treatment attenuates depletion of ovarian reserve associated with cyclophosphamide therapy in premenopausal SLE patients.
Marder W; McCune WJ; Wang L; Wing JJ; Fisseha S; McConnell DS; Christman GM; Somers EC
Gynecol Endocrinol; 2012 Aug; 28(8):624-7. PubMed ID: 22296584
[TBL] [Abstract][Full Text] [Related]
8. Assessment of anti-Müllerian hormone levels in premenopausal patients with systemic lupus erythematosus.
Gasparin AA; Souza L; Siebert M; Xavier RM; Chakr RM; Palominos PE; Brenol JC; Monticielo OA
Lupus; 2016 Mar; 25(3):227-32. PubMed ID: 26223296
[TBL] [Abstract][Full Text] [Related]
9. Ovarian reserve in adult patients with childhood-onset lupus: a possible deleterious effect of methotrexate?
de Araujo DB; Yamakami LY; Aikawa NE; Bonfá E; Viana VS; Pasoto SG; Pereira RM; Serafin PC; Borba EF; Silva CA
Scand J Rheumatol; 2014; 43(6):503-11. PubMed ID: 24881927
[TBL] [Abstract][Full Text] [Related]
10. Ovarian reserve diminished by oral cyclophosphamide therapy for granulomatosis with polyangiitis (Wegener's).
Clowse ME; Copland SC; Hsieh TC; Chow SC; Hoffman GS; Merkel PA; Spiera RF; Davis JC; McCune WJ; Ytterberg SR; St Clair EW; Allen NB; Specks U; Stone JH;
Arthritis Care Res (Hoboken); 2011 Dec; 63(12):1777-81. PubMed ID: 22127969
[TBL] [Abstract][Full Text] [Related]
11. Study of anti-Müllerian hormone and its relation to the subsequent probability of pregnancy in 112 patients with systemic lupus erythematosus, exposed or not to cyclophosphamide.
Morel N; Bachelot A; Chakhtoura Z; Ghillani-Dalbin P; Amoura Z; Galicier L; Aumaitre O; Piette JC; Pourrat J; Boutin D; Sacre K; Kahn JE; Duhaut P; Farge D; Francès C; Guettrot-Imbert G; Harlé JR; Lambotte O; Le Guern V; Sène D; Trad S; Vidal E; Sarrot-Reynauld F; Gompel A; Tanguy ML; Touraine P; Lacorte JM; Costedoat-Chalumeau N;
J Clin Endocrinol Metab; 2013 Sep; 98(9):3785-92. PubMed ID: 23833039
[TBL] [Abstract][Full Text] [Related]
12. Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide.
Houssiau FA; Vasconcelos C; D'Cruz D; Sebastiani GD; Garrido Ed Ede R; Danieli MG; Abramovicz D; Blockmans D; Mathieu A; Direskeneli H; Galeazzi M; Gül A; Levy Y; Petera P; Popovic R; Petrovic R; Sinico RA; Cattaneo R; Font J; Depresseux G; Cosyns JP; Cervera R
Arthritis Rheum; 2002 Aug; 46(8):2121-31. PubMed ID: 12209517
[TBL] [Abstract][Full Text] [Related]
13. Ovarian dysfunction with moderate-dose intravenous cyclophosphamide (modified NIH regimen) and mycophenolate mofetil in young adults with severe lupus: a prospective cohort study.
Sharma SK; Jain S; Bahl P; Potturi P; Rathi M; Naidu S; Sachdeva N; Dhir V; Jain S
Arthritis Res Ther; 2020 Aug; 22(1):189. PubMed ID: 32799907
[TBL] [Abstract][Full Text] [Related]
14. Anti-Müllerian hormone in African-American women with systemic lupus erythematosus.
Angley M; Spencer JB; Lim SS; Howards PP
Lupus Sci Med; 2020 Nov; 7(1):. PubMed ID: 33132225
[TBL] [Abstract][Full Text] [Related]
15. Ovarian function is preserved in women with severe systemic lupus erythematosus after a 6-month course of cyclophosphamide followed by mycophenolate mofetil.
Laskari K; Zintzaras E; Tzioufas AG
Clin Exp Rheumatol; 2010; 28(1):83-6. PubMed ID: 20346244
[TBL] [Abstract][Full Text] [Related]
16. Subclinical impairment of ovarian reserve in juvenile systemic lupus erythematosus after cyclophosphamide therapy.
Aikawa NE; Sallum AM; Pereira RM; Suzuki L; Viana VS; Bonfá E; Silva CA
Clin Exp Rheumatol; 2012; 30(3):445-9. PubMed ID: 22703605
[TBL] [Abstract][Full Text] [Related]
17. Impact of systemic lupus erythematosus on ovarian reserve in premenopausal women: evaluation by using anti-Muellerian hormone.
Lawrenz B; Henes J; Henes M; Neunhoeffer E; Schmalzing M; Fehm T; Kïtter I
Lupus; 2011 Oct; 20(11):1193-7. PubMed ID: 21768179
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for ovarian failure in patients with systemic lupus erythematosus receiving cyclophosphamide therapy.
Mok CC; Lau CS; Wong RW
Arthritis Rheum; 1998 May; 41(5):831-7. PubMed ID: 9588734
[TBL] [Abstract][Full Text] [Related]
19. Use of a gonadotropin-releasing hormone analog for protection against premature ovarian failure during cyclophosphamide therapy in women with severe lupus.
Somers EC; Marder W; Christman GM; Ognenovski V; McCune WJ
Arthritis Rheum; 2005 Sep; 52(9):2761-7. PubMed ID: 16142702
[TBL] [Abstract][Full Text] [Related]
20. [A multicenter study on the tolerance of intravenous low-dose cyclophosphamide in systemic lupus erythematosus].
Shao M; Guo HF; Lei LY; Zhao Q; Ding YJ; Lin J; Wu R; Yu F; Li YC; Miao HL; Zhang LY; DU Y; Jiao RY; Pang LX; Long L; Li ZG; Li R
Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 54(6):1112-1116. PubMed ID: 36533341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
